ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Two Children Achieve Remission With CD19 Immunotherapy

March 29, 2013

In Brief: Judge Rules FDA Modernization Act Violates First Amendment Over Publications Policy

August 6, 1999

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

Roche Reports New Avastin Results As FDA Mulls Breast Cancer Indication.

February 15, 2008

In Brief: Mark Kochevar Named New Administrative Officer Of DCE; Thomas Necheles Dies Suddenly at 51

September 21, 1984

October issue of Business & Regulatory Report (8-page issue).

November 2, 2002